Resources
Search our resources for user guides, checklists, international scientific guidelines, compositional guidelines and forms.
Can't find what you’re looking for? You can also:
- search our Publications
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Prescription medicines (208)
- Complementary medicines (116)
- Therapeutic goods regulation (92)
- Listed medicines (84)
- Over the counter (OTC) medicines (51)
- Biological medicines (50)
- Non-prescription medicines (41)
- Manufacturing (37)
- In Vitro Diagnostic medical devices (IVDs) (28)
- Medicines safety (24)
- Safety (22)
- Regulatory compliance (20)
- Medical devices safety (19)
- Advertising (18)
- Assessed listed medicines (16)
- Scheduling (national classification system) (16)
- Clinical trials (14)
- Labelling and packaging (14)
- Legislation (14)
- Medicinal cannabis hub (13)
- Registered complementary medicines (13)
- Import and export (12)
- Australian Register of Therapeutic Goods (ARTG) (11)
- Disinfectants/Sterilants (7)
- COVID-19 (6)
- Shortages (6)
- Vaping hub (6)
- Electronic submissions (5)
- Fees and payments (5)
- Blood and blood components (4)
- TGA conformity assessment certification (4)
- Advisory bodies and committees (3)
- Alert/Advisory (3)
- Pharmacovigilance (3)
- Sunscreens (3)
- COVID-19 vaccines (2)
- Metal-on-metal hip replacement implants hub (2)
- Blood safety (1)
- Implantable medical devices (1)
- Personalised medical devices (1)
- Prescription opioids hub (1)
- Software as a medical device (1)
Results for
"[search-keyword]"
Search
889 result(s) found, displaying 501 to 525
-
Reference materialLearn how prescription medicines are regulated in Australia
-
Reference materialCertain folate substances presented as foods or dietary management products have been declared therapeutic goods
-
Reference materialQuestions and answers about the Medical device Incident Reporting and Investigation Scheme
-
Reference materialTGA Laboratory testing - Contamination of ranitidine medicines with the nitrosamine NDMA
-
User guideElectronic data interchange for ICSR submission using the E2B R2 format
-
Reference materialAdditional Q&A's on use of market authorisation evidence from overseas regulatory bodies for medical devices
-
User guideA how to fill in a device incident report
-
Reference materialAdvisory Committee on Medicines Scheduling to consider upscheduling of modified release paracetamol to 'Pharmacist Only'
-
Compositional guidelinesCompositional guideline for 'Streptococcus salivarius M18' permitted for use in listed medicines
-
Reference materialIn addition to the legislated requirements, there are other features of leaflet and card design that can be very helpful for patients
-
Reference materialGuidance on how the Poisons Standard is amended and details of the processes that underpin the scheduling policy
-
Reference materialIf you are considering a cosmetic injection, use this information to carefully research both the products and the health practitioners involved.
-
Compositional guidelinesCompositional guideline for 'Calcified Lithothamnion species' permitted for use in listed medicines
-
Compositional guidelinesCompositional guideline for 'Resveratrol' permitted for use in listed medicines
-
-
Reference materialThings to keep in mind when you see the ‘TGA assessed’ symbol or statement
-
Reference materialThe TGA has published a list of FAQs on issues raised by industry in relation to permitted indications
-
Reference materialRisk management plans for medicines and biologicals has been updated with new content, new Australia-Specific Annex and a new form
-
-
User guideUser guide on the Adverse Event Management System (AEMS) for health professionals.
-
-
Reference materialImportant information about potential impact of regulation changes that came in force on 1 July 2018
-
Reference materialEffective 1 October 2018 TGA has made a new determination which excludes certain goods from the operation of the Act
-
Reference materialGuidance on colourings in medicines for topical and oral use
-
FormsChecklist to assist in a priority review designation application